ATE122395T1 - Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen. - Google Patents

Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.

Info

Publication number
ATE122395T1
ATE122395T1 AT90914243T AT90914243T ATE122395T1 AT E122395 T1 ATE122395 T1 AT E122395T1 AT 90914243 T AT90914243 T AT 90914243T AT 90914243 T AT90914243 T AT 90914243T AT E122395 T1 ATE122395 T1 AT E122395T1
Authority
AT
Austria
Prior art keywords
proteins
particles
virus
vaccines
production
Prior art date
Application number
AT90914243T
Other languages
English (en)
Inventor
Caroline Sarah Brown
Original Assignee
Univ Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19855310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE122395(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leiden filed Critical Univ Leiden
Application granted granted Critical
Publication of ATE122395T1 publication Critical patent/ATE122395T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14323—Virus like particles [VLP]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90914243T 1989-09-14 1990-09-11 Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen. ATE122395T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8902301A NL8902301A (nl) 1989-09-14 1989-09-14 Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.

Publications (1)

Publication Number Publication Date
ATE122395T1 true ATE122395T1 (de) 1995-05-15

Family

ID=19855310

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90914243T ATE122395T1 (de) 1989-09-14 1990-09-11 Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.

Country Status (7)

Country Link
EP (1) EP0491824B2 (de)
AT (1) ATE122395T1 (de)
DE (1) DE69019359T3 (de)
DK (1) DK0491824T4 (de)
ES (1) ES2073036T5 (de)
NL (1) NL8902301A (de)
WO (1) WO1991004330A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92298A (en) * 1988-11-14 2001-04-30 Us Secretary U S Dept Of Comme Method for producing isolated empty b19 parvovirus capsids, introducing genes into cells utilizing the same, diagnostic assays for detecting parvovirus infection and an anti-parvovirus vaccine containing said capsids
US7476389B1 (en) * 1991-07-19 2009-01-13 The University Of Queensland Papillomavirus vaccines
ES2048646B1 (es) * 1992-04-15 1994-10-01 Ercros Sa Procedimiento para la obtencion de la proteina vp2 del virus de la peste equina africana (ahsv)
US5437951A (en) 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
CA2175256A1 (en) * 1993-10-28 1995-05-04 Andrea Kern Adeno-associated virus - its diagnostic use with early abortion
AU5103396A (en) * 1995-03-08 1996-09-23 Klaus Hedman Method for the diagnosis of injections
ES2282998T3 (es) * 1996-01-02 2007-10-16 Institut Pasteur Pseudo-particularmente viricas recombinadas y aplicaciomnes vacunales y antitumorales.
FR2771751B1 (fr) 1997-12-03 2000-05-26 Assist Publ Hopitaux De Paris Erythrovirus et ses applications
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
SE520177C2 (sv) * 1998-11-24 2003-06-03 Kristina Broliden Användning av tomma, icke-infektiösa, rekombinanta parvoviruskapsidpartiklar, eller P-antigenblockerande delar därav, för framställning av läkemedel för ihibering av hematopoietiska stamceller
US6818612B2 (en) 1998-11-24 2004-11-16 Kristina Broliden Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
US6743772B1 (en) 1998-11-24 2004-06-01 Kristina Broliden Use of parovirus capsid particles in the inhibition of cell proliferation and migration
HU230244B1 (hu) 2001-06-28 2015-11-30 Novartis Vaccines And Diagnostics, Inc. Diagnosztikai esszék a B19 parvovírushoz
CA2572129A1 (en) * 2004-07-01 2006-01-12 The Circle For The Promotion Of Science And Engineering Viral particle-like construct and method of forming the same under physiological conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine

Also Published As

Publication number Publication date
DE69019359T3 (de) 2006-09-07
ES2073036T3 (es) 1995-08-01
DK0491824T3 (da) 1995-07-17
DK0491824T4 (da) 2006-05-08
ES2073036T5 (es) 2006-08-01
EP0491824B2 (de) 2006-04-12
DE69019359T2 (de) 1995-10-12
DE69019359D1 (de) 1995-06-14
EP0491824B1 (de) 1995-05-10
WO1991004330A1 (en) 1991-04-04
NL8902301A (nl) 1991-04-02
EP0491824A1 (de) 1992-07-01

Similar Documents

Publication Publication Date Title
DE69019359D1 (de) Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.
ATE181572T1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
WO2002032962A3 (en) Compositions of human proteins and method of use thereof
DE69731289D1 (de) Immunglobulinähnliche domäne mit erhöhten halbwertszeiten
DE3886506D1 (de) Avirulente mikroben und deren verwendungen.
NO20012812L (no) Vaksinesammensetning og vaksine samt anvendelse av polypeptid og polynukletid
NO902802D0 (no) Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus.
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
EP1289551A4 (de) HUMANE POLYPEPTIDE WELCHE ZUM ABSTERBEN VON ZELLEN, INSBESONDERE LYMPHOIDER TUMORZELLEN, FüHREN
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
ATE236980T1 (de) Huehner-anaemie-virus mutante, impfstoffe, und verwendung basiert auf virusproteinen vp1, vp2 und vp3, oder dafuer kodierende virus-sequenzen
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
ATE159170T1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
DE69031351D1 (de) Zubereitungen und behandlungen von pneumonia in tieren
ATE237691T1 (de) Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
WO1996009391A3 (en) Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
DE60140559D1 (de) 32144, eine humane fettsäureamid-hydrolase und deren verwendungen
ATE181104T1 (de) Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
DE60237613D1 (de) Neue pgc-1-isoformen und deren verwendungen
ATE470716T1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407
ATE433489T1 (de) 16836, ein mitglied der humanen phospholipase c familie und seine verwendungen
DE60237236D1 (de) Ein mitglied der menschlichen proteinkinasefamilie, und verwendungen dafür

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0491824

Country of ref document: EP

EELA Cancelled due to lapse of time